Ricin induces IL-8 secretion from human monocyte/macrophages by activating the p38 MAP kinase pathway

Tessa V Gonzalez1, Stephanie A Farrant, Nicholas J Mantis

  • 1Department of Pediatrics, Harvard Medical School, and GI Cell Biology Laboratory, Children's Hospital Boston, Boston, MA 02115, USA.

Molecular Immunology
|January 26, 2006
PubMed

Insights

Ricin toxin triggers human immune cells to release IL-8, a key molecule in inflammation. This process involves the p38 MAPK pathway, suggesting potential therapeutic targets for ricin-induced inflammation.

Area of Science:

  • Immunology
  • Toxicology
  • Cell Biology

Background:

  • Polymorphonuclear cell (PMN) infiltration is characteristic of ricin-induced mucosal inflammation.
  • The specific cellular mechanisms initiating this inflammatory response are not fully understood.

Purpose of the Study:

  • To investigate the cellular response of human monocyte/macrophages to ricin exposure.
  • To identify the signaling pathways involved in ricin-induced IL-8 secretion.

Main Methods:

  • Human monocyte/macrophage cell line (28SC) was exposed to ricin.
  • Interleukin-8 (IL-8) secretion levels were measured.
  • The role of p38 mitogen-activated protein kinase (MAPK) was assessed using an inhibitor (SB203580).

Main Results:

  • Ricin stimulated 28SC cells to secrete IL-8 in a dose- and time-dependent manner.
  • IL-8 secretion was dependent on active ricin translocation and involved p38 MAPK activation.
  • Inhibition of p38 MAPK suppressed ricin-induced IL-8 release.

Conclusions:

  • Ricin induces IL-8 production in human monocyte/macrophages via p38 MAPK pathway activation.
  • This finding suggests p38 MAPK inhibitors could be potential therapeutics for ricin intoxication-related mucosal inflammation.